San Francisco
Dr. David Anschütz
Principal Associate
San Francisco: +1 415 400 22 00
Frankfurt am Main: +49 69 27 30 80
About
David is a principal associate in our Private Capital / M&A team and a member of our global transactions group.
He has broad experience advising financial sponsors and corporations on domestic and cross-border M&A transactions across a variety of industries.
David is based in Frankfurt and currently on secondment in San Francisco / Silicon Valley.
He speaks German and English.
Additional Information
- Arteris, Inc. on its acquisition of Cycuity
- Merck KGaA on the acquisition of the chromatography business of JSR Life Sciences
- Klocke Group and IDT Biologika on strategic partnership with SK bioscience
- One Equity Partners on the sale of Walki to Oji Holdings Corporation
- One Equity Partners on the acquisition of Fortaco group from CapMan Buyout
- International Chemical Investors Group on the sale of Corden Pharma to Astorg
- Corden Pharma on the acquisition of three production sites from Vifor Pharma
- Lindsay Goldberg on the sale of PACCOR group to Faerch group
- One Equity Partners on the sale of Lutech to Apax
- One Equity Partners on the acquisition of a 29% stake in Cicor Technologies AG from HEB Swiss Investment AG
Dr. David Anschütz
Principal Associate
San Francisco Office
One Bush Street
17th Floor
San Francisco 94104
Frankfurt am Main Office
Große Gallusstraße 14
Frankfurt am Main 60315